10-Q · October 30, 2025
The extracted filing text does not include the financial statements or MD&A, so revenue, margins, EPS, balance-sheet trends, cash flow, and segment performance cannot be assessed. Nasdaq confirmed compliance with the…
Earnings analysis · 10-Q
CNSY earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q extract is limited primarily to Part II and does not include income-statement, balance-sheet, cash-flow, segment, or MD&A financial data; therefore revenue, margins, EPS, cash flow, and working-capital…
Read full summary
The supplied 10-Q extract is limited primarily to Part II and does not include income-statement, balance-sheet, cash-flow, segment, or MD&A financial data; therefore revenue, margins, EPS, cash flow, and working-capital trends cannot be assessed from the filing text provided. Disclosure controls were deemed effective as of June 30, 2026, with no material changes in internal control over financial reporting. Management reported no legal proceedings and no material changes to the risk factors from the 2025 Form 10-K, while the filing provides no quantitative guidance.
What stood out
-
Disclosure controls deemed effective
Management concluded that disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2026.
-
No material control changes
The company reported that there were no changes in internal control over financial reporting during the quarter ended June 30, 2026, that materially affected or were reasonably likely to materially affect those controls.
-
No legal proceedings reported
The filing reports no legal proceedings under Part II, Item 1.
-
No reported equity transactions
The company reported no unregistered sales of equity securities, no use of proceeds from registered securities, and no purchases of equity securities during the reporting period.
-
Lease amendment filed
The filing includes a First Amendment to the lease dated August 10, 2026, as Exhibit 10.3, with portions redacted under Item 601(b)(10)(iv) of Regulation S-K.
What to watch
-
No updated risk-factor disclosure
The filing states, verbatim, that there have been no material changes to the risk factors disclosed in Part I, Item 1A of the 2025 Form 10-K. Accordingly, no new or modified risk-factor disclosure was identified in this 10-Q.
-
Equity distribution financing risk
The company filed an Equity Distribution Agreement with Canaccord Genuity LLC dated June 1, 2026. The supplied extract does not disclose sales under the agreement or its remaining capacity, so potential financing-related dilution cannot be quantified.
-
Recent corporate charter changes
The filing includes a Certificate of Amendment to the Amended and Restated Certificate of Incorporation effective August 3, 2026, and Second Amended and Restated Bylaws filed August 4, 2026; the supplied extract does not explain their economic implications.
Management's outlook
No quantitative revenue or EPS outlook is disclosed in the supplied 10-Q extract; numeric guidance fields are therefore null.
Earlier filings 1
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.